PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

26 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Luo, H. et al.: Association of plasma proteomics with mortality in individuals with and without type 2 diabetes: Results from two population-based KORA cohort studies. BMC Med. 22:420 (2024)
2.
Van Rampelbergh, J.* et al.: First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers. BMC Med. 22:259 (2024)
3.
Wagner, R. et al.: Carrageenan and insulin resistance in humans: A randomised double-blind cross-over trial. BMC Med. 22:558 (2024)
4.
Zeng, F.* et al.: Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults. BMC Med. 22:104 (2024)
5.
Fosse, V.* et al.: Recommendations for robust and reproducible preclinical research in personalised medicine. BMC Med. 21:14 (2023)
6.
Gill, D.* et al.: The citrate transporter SLC13A5 as a therapeutic target for kidney disease: Evidence from Mendelian randomization to inform drug development. BMC Med. 21:504 (2023)
7.
Lin, J. et al.: Proteomic profiling of longitudinal changes in kidney function among middle-aged and older men and women: The KORA S4/F4/FF4 study. BMC Med. 21:245 (2023)
8.
Rothwell, J.A.* et al.: Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. BMC Med. 21:80 (2023)
9.
Van Rampelbergh, J.* et al.: First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Med. 21:190 (2023)
10.
Yaskolka Meir, A.* et al.: The effect of polyphenols on DNA methylation-assessed biological age attenuation: The DIRECT PLUS randomized controlled trial. BMC Med. 21:364 (2023)
11.
Breeur, M.* et al.: Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20:351 (2022)
12.
Freuer, D.* ; Linseisen, J. & Meisinger, C.*: Asthma and the risk of gastrointestinal disorders: A Mendelian randomization study. BMC Med. 20:82 (2022)
13.
Zelicha, H.* et al.: The effect of high-polyphenol Mediterranean diet on visceral adiposity: The DIRECT PLUS randomized controlled trial. BMC Med. 20:327 (2022)
14.
Andörfer, L.* et al.: Salivary metabolites associated with a 5-year tooth loss identified in a population-based setting. BMC Med. 19:161 (2021)
15.
Rübsamen, N.* et al.: Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study. BMC Med. 19:38 (2021)
16.
Johar, H. et al.: Evaluation of antenatal risk factors for postpartum depression: A secondary cohort analysis of the cluster-randomised GeliS trial. BMC Med. 18:227 (2020)
17.
Rothenbacher, D.* et al.: Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: The BiomarCaRE project. BMC Med. 18:300 (2020)
18.
Seyed Khoei, N.* et al.: Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med. 18:229 (2020)
19.
Hoffmann, V. et al.: Landmark models to define the age-adjusted risk of developing stage 1 type 1 diabetes across childhood and adolescence. BMC Med. 17:125 (2019)
20.
Santos, S.* et al.: Gestational weight gain charts for different body mass index groups for women in Europe, North America, and Oceania. BMC Med. 16:201 (2018)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮